Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 134

    Indoco Remedies

    Indoco Remedies' new solid dosages facility at Baddi gets UK-MHRA nod

    Farhat Nasim11 May 2019 10:00 AM IST
    Indoco Remedies' new Baddi facility is spread over an area of 18000 sqm, with a manufacturing capacity of 4.3 billion tablets and 50 million capsules...
    GSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 crore

    GSK Consumer Healthcare Q4 profit up 35 percent to Rs 285 crore

    Garima11 May 2019 9:35 AM IST
    In a separate filing, GSK Consumer Healthcare informed that its board has recommended a dividend at the rate of Rs 105 per equity share of Rs 10...
    Pfizer gets USFDA approval for Vyndaqel, Vyndamax to treat amyloidosis cardiomyopathy

    Pfizer gets USFDA approval for Vyndaqel, Vyndamax to treat amyloidosis cardiomyopathy

    Farhat Nasim11 May 2019 9:15 AM IST
    New Delhi: Pfizer Inc's subsidiary FoldRx, has recently won U.S. Food and Drug Administration (USFDA) approved for Vyndaqel (tafamidis meglumine) and...
    Indivior signs deal to sell schizophrenia drug Perseris in Canada

    Indivior signs deal to sell schizophrenia drug Perseris in Canada

    Garima11 May 2019 9:10 AM IST
    Perseris, launched in the United States in February, is approved by the FDA for the treatment of schizophrenia in adults.U.S: British drugmaker...
    Following opioid suits, family behind deadly OxyContin squabbles

    Following opioid suits, family behind deadly OxyContin squabbles

    Medical Dialogues Bureau11 May 2019 9:00 AM IST
    NEW YORK: A united front among members of the billionaire Sackler family behind painkiller OxyContin is showing signs of strain from litigation over...
    Lupin launches generic Clobazam tablets to treat seizures

    Lupin launches generic Clobazam tablets to treat seizures

    Farhat Nasim10 May 2019 10:45 AM IST
    The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Food and Drug...
    HealthKart raises USD 25 million from Sofina to expand offline network

    HealthKart raises USD 25 million from Sofina to expand offline network

    Garima10 May 2019 10:05 AM IST
    HealthKart will use the funds to expand its offline store network, develop additional direct-to-consumer nutrition brands and strengthen its vertical...
    Lupin, Aptissen sign pact to sell Osteoarthritis injection Synolis in Canada

    Lupin, Aptissen sign pact to sell Osteoarthritis injection Synolis in Canada

    Garima10 May 2019 9:30 AM IST
    Synolis VA (Visco-Antalgic) is the intra-articular injection product for osteoarthritis with a unique combination of Hyaluronic Acid and high...
    Trump says he will allow US states to buy cheaper medicines from abroad

    Trump says he will allow US states to buy cheaper medicines from abroad

    Medical Dialogues Bureau10 May 2019 9:20 AM IST
    WASHINGTON: The Trump administration is working to allow U.S. states to buy prescription drugs from other countries if the medications cost less,...
    Washington: Drugmakers will have to reveal medicine prices in TV ads

    Washington: Drugmakers will have to reveal medicine prices in TV ads

    Medical Dialogues Bureau10 May 2019 9:10 AM IST
    Health and Human Services Secretary Alex Azar said the Trump administration has finalized regulations that will require drug companies to disclose...
    AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise

    AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise

    Medical Dialogues Bureau10 May 2019 9:00 AM IST
    The treatment Trastuzumab Deruxtecan, or DS-8201, demonstrated a clinically meaningful response in patients with refractory HER2-positive metastatic...
    Not passing GST benefit to consumers: Abbott gets HC relief after Challenging powers of National Anti-Profiteering Authority

    Not passing GST benefit to consumers: Abbott gets HC relief after Challenging powers of National Anti-Profiteering Authority

    Farhat Nasim9 May 2019 2:11 PM IST
    New Delhi: In an interim relief, the Delhi High Court has stayed proceedings against Abbott Healthcare which was found guilty by the National...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDA shuts six medical stores in Haryana due to irregularities

    FDA shuts six medical stores in Haryana due to irregularities

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    AYUSH ministry launches e-AUSHADHI portal for online licensing of drugs

    AYUSH ministry launches e-AUSHADHI portal for online licensing of drugs

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok